Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07820254) titled 'Inspiratory Flow Rate Capability in Pulmonary Fibrosis Patients' on Sept. 10.

Study Type: Observational

Primary Sponsor: Shanghai Pulmonary Hospital, Shanghai, China

Condition: Idiopathic Pulmonary Fibrosis Progressive Pulmonary Fibrosis

Recruitment Status: Recruiting

Date of First Enrollment: January 10, 2026

Target Sample Size: 60

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07820254

Disclaimer: Curated by HT Syndication....